Cholesterol drug may lower risk for death and cardiovascular events
Alirocumab significantly decreased severe cardiovascular risks in patients with acute coronary syndrome.
Acute Coronary Syndrome
Noninvasive coronary testing may prevent need for future invasive tests
Low-risk acute coronary syndrome patients may require fewer referrals for invasive coronary angiography if they had initial noninvasive testing such as stress echocardiography or cardiovascular magnetic resonance.
Same-day discharge may be safe for patients after percutaneous coronary intervention
Same-day discharge after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes was not predictive of 30-day readmission, death, or bleeding.
Shared decision making boosts patients’ knowledge of acute coronary syndrome risk
The use of a decision aid in patients at risk of acute coronary syndrome increased patient knowledge about their risk.
Chest pain in ER patients rarely life threatening
Only 5.5% of ER patients are diagnosed with 1 of 6 life threatening conditions.
Smartphone app helps circumvent unnecessary testing for chest pain in ED patients
The HEART pathway app provides doctors in the ED with a digital application an already proven method of assessment.
Blood thinner for treatment of ACS
Ticagrelor significantly reduced the rate of cardiovascular death, MI or stroke compared with clopidogrel in a clinical trial.
Next post in Drug Update
